Tech — Software
Tempus AI Executive Compensation (FY25)
TEM · Executive and director compensation, fiscal 2023 to 2025
Data as of September 7, 2026Latest filing (DEF 14A): April 7, 2026
157 figures on this page, cited to the filing that reported them. See the citations
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Eric Lefkofsky: $28,555,040 → $41,495,833 (45.3% higher)
Frequently asked questions
Answers drawn from the data on this page.
Who is Tempus AI's chief executive and what were they paid?
Eric Lefkofsky was paid $41,495,833 in total compensation as Chief Executive Officer, Founder and Chairman for fiscal 2025. Lefkofsky's total was 45.3% higher than the $28,555,040 reported for fiscal 2024.
Which companies are in Tempus AI's peer group?
The disclosed peer group includes 10x Genomics, C3.ai, Caris Life Sciences, Doximity and Exact Sciences, among others.
Executive compensation
Every element reported for each named executive officer, by fiscal year.
Fiscal 2023
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
James Rogers Chief Financial Officer | ◇ | ◇ | ◇ | — | — | — | ◇ | ◇ |
Eric Lefkofsky Chief Executive Officer, Founder and Chairman | — | — | — | — | — | — | ◇ | ◇ |
Fiscal 2024
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Eric Lefkofsky Chief Executive Officer, Founder and Chairman | — | ◇ | ◇ | — | — | — | ◇ | ◇ |
Ryan Fukushima Chief Operating Officer | ◇ | ◇ | ◇ | — | — | — | ◇ | ◇ |
Andrew Polovin Executive Vice President, General Counsel and Secretary | ◇ | — | ◇ | — | — | — | ◇ | ◇ |
James Rogers Chief Financial Officer | ◇ | ◇ | ◇ | — | — | — | — | ◇ |
Fiscal 2025
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Eric Lefkofsky Chief Executive Officer, Founder and Chairman | ◇ | — | ◇ | — | ◇ | — | — | ◇ |
Ryan Fukushima Chief Executive Officer, Data | ◇ | ◇ | ◇ | — | ◇ | — | ◇ | ◇ |
Andrew Polovin Executive Vice President, Chief Legal Officer and Secretary | ◇ | — | ◇ | — | ◇ | — | — | ◇ |
James Rogers Chief Financial Officer | ◇ | — | ◇ | — | ◇ | — | — | ◇ |
Erik Phelps Executive Vice President, Chief Administrative and Legal Officer and Assistant Secretary | ◇ | ◇ | ◇ | — | ◇ | — | ◇ | ◇ |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.
Equity awards granted
Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
| Officer | Award | Grant date | Threshold units | Target units | Units granted | Maximum units | Exercise price | Grant date fair value |
|---|---|---|---|---|---|---|---|---|
| Andrew Polovin | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Andrew Polovin | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Eric Lefkofsky | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Erik Phelps | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Erik Phelps | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| James Rogers | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| James Rogers | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Ryan Fukushima | RSU | ◇ | — | — | ◇ | — | — | ◇ |
Fiscal 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.
Outstanding awards
Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
| Officer | Award | Unvested units | Market value of unvested units | Exercise price | Expires |
|---|---|---|---|---|---|
| James Rogers | RSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Ryan Fukushima | RSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Erik Phelps | RSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Andrew Polovin | RSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Eric Lefkofsky | RSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Director compensation
What each non-employee director was paid.
Fiscal 2025
| Director | Fees earned in cash | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|
Peter J. Barris | ◇ | ◇ | — | — | — | — | ◇ |
Jennifer A. Doudna, Ph.D | ◇ | ◇ | — | — | — | — | ◇ |
David R. Epstein | ◇ | ◇ | — | — | — | — | ◇ |
Nadja West, M.D | ◇ | ◇ | — | — | — | — | ◇ |
Eric D. Belcher | ◇ | ◇ | — | — | — | — | ◇ |
Wayne A.I. Frederick, M.D | ◇ | ◇ | — | — | — | — | ◇ |
Scott Gottlieb, M.D | ◇ | ◇ | — | — | — | — | ◇ |
Theodore J. Leonsis | ◇ | ◇ | — | — | — | — | ◇ |
Robert Ghenchev and Eric Lefkofsky served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Director fee schedule
The standing retainers and premiums the board pays, as published.
| Board cash retainer | ◇ |
| Board equity retainer | ◇ |
| Total board retainer | ◇ |
| Lead independent director premium | ◇ |
| Audit committee member | ◇ |
| Compensation committee member | ◇ |
| Nominating and governance member | ◇ |
Equity is delivered as restricted stock units.
Disclosed peer group
The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
- 10x Genomics TXG
- C3.ai AI
- Caris Life Sciences CAI
- Doximity DOCS
- Exact Sciences EXAS
- GeneDx Holdings WGS
- GRAIL GRAL
- Guardant Health GH
- Illumina ILMN
- IQVIA Holdings IQV
- Natera NTRA
- Recursion Pharmaceuticals RXRX
- Veeva Systems VEEV
What this page does not include
Everything above is a fact Tempus AI disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Tempus AI sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $1,200Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion IntelligenceAdviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Enquire about accessMultiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion IntelligenceCitations
Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
157 figures on this page, cited to the filing that reported them.
157 cited to the filing
Documents cited
- 0001193125-26-145528Director Compensation · Grants of Plan-Based Awards · Non-Employee Director Compensation · Outstanding Equity Awards as of December 31, 2025 · and 1 more section
- 0001193125-25-074642Summary Compensation Table
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Tempus AI executive compensation, FY2023–FY2025.” https://intel.velarion.ai/comp/TEM (accessed 2026).
Short form: data: Velarion
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Tempus AI and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Tech — Software rankings
Peers Tempus AI discloses
The companies named in TEM's own disclosed peer group.
Terms on this page
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
author = {{Velarion Company Intelligence}},
title = {Velarion database: executive and board compensation data},
year = {2026},
version = {2026Q3},
doi = {10.5281/zenodo.22283854},
publisher = {Zenodo},
url = {https://doi.org/10.5281/zenodo.22283854}
}